These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia. Arrieta AC; Bradley JS; Popejoy MW; Bensaci M; Grandhi A; Bokesch P; Glasser C; Du L; Patino H; Kartsonis NA Pediatr Infect Dis J; 2018 Sep; 37(9):893-900. PubMed ID: 29406465 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty. Byren I; Rege S; Campanaro E; Yankelev S; Anastasiou D; Kuropatkin G; Evans R Antimicrob Agents Chemother; 2012 Nov; 56(11):5626-32. PubMed ID: 22908174 [TBL] [Abstract][Full Text] [Related]
4. Management of Pediatric Acute Hematogenous Osteomyelitis, Part II: A Focus on Methicillin-Resistant Staphylococcus aureus, Current and Emerging Therapies. DeRonde KJ; Girotto JE; Nicolau DP Pharmacotherapy; 2018 Oct; 38(10):1021-1037. PubMed ID: 29989190 [TBL] [Abstract][Full Text] [Related]
5. Ceftobiprole for Treatment of Complicated Holland TL; Cosgrove SE; Doernberg SB; Jenkins TC; Turner NA; Boucher HW; Pavlov O; Titov I; Kosulnykov S; Atanasov B; Poromanski I; Makhviladze M; Anderzhanova A; Stryjewski ME; Assadi Gehr M; Engelhardt M; Hamed K; Ionescu D; Jones M; Saulay M; Smart J; Seifert H; Fowler VG; N Engl J Med; 2023 Oct; 389(15):1390-1401. PubMed ID: 37754204 [TBL] [Abstract][Full Text] [Related]
7. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial. Konychev A; Heep M; Moritz RK; Kreuter A; Shulutko A; Fierlbeck G; Bouylout K; Pathan R; Trostmann U; Chaves RL Drugs Aging; 2013 Oct; 30(10):829-36. PubMed ID: 23990341 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE; N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701 [TBL] [Abstract][Full Text] [Related]
10. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS; JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345 [TBL] [Abstract][Full Text] [Related]
12. Daptomycin in bone and joint infections: a review of the literature. Rice DA; Mendez-Vigo L Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686 [TBL] [Abstract][Full Text] [Related]
13. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Katz DE; Martone WJ Clin Ther; 2007 Nov; 29(11):2440-7. PubMed ID: 18158084 [TBL] [Abstract][Full Text] [Related]
14. Current data on acute haematogenous osteomyelitis in children in Southern Israel: epidemiology, microbiology, clinics and therapeutic consequences. Cohen E; Lifshitz K; Fruchtman Y; Eidelman M; Leibovitz E Int Orthop; 2016 Sep; 40(9):1987-94. PubMed ID: 27169533 [TBL] [Abstract][Full Text] [Related]
15. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial. Shaw E; Miró JM; Puig-Asensio M; Pigrau C; Barcenilla F; Murillas J; Garcia-Pardo G; Espejo E; Padilla B; Garcia-Reyne A; Pasquau J; Rodriguez-Baño J; López-Contreras J; Montero M; de la Calle C; Pintado V; Calbo E; Gasch O; Montejo M; Salavert M; Garcia-Pais MJ; Carratalà J; Pujol M; ; ; BMJ Open; 2015 Mar; 5(3):e006723. PubMed ID: 25762232 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry. Martone WJ; Lamp KC Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448 [TBL] [Abstract][Full Text] [Related]
17. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin. Vikram HR; Havill NL; Koeth LM; Boyce JM J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025 [TBL] [Abstract][Full Text] [Related]
18. Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Hoyer EA; Joseph M; Kaplan SL; Vallejo JG; McNeil JC Pediatr Infect Dis J; 2023 Jun; 42(6):449-455. PubMed ID: 36795576 [TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355 [TBL] [Abstract][Full Text] [Related]
20. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]